USFDA Raises Safety Alert on Amgen's Tavneos After Liver Injury, Death Cases Surface sheeba farhat5 April 2026 10:00 AM ISTBengaluru: The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen's drug for a group of...
AI Reshapes Drug Development Workflows, But Breakthrough Molecules Still Elusive sheeba farhat27 Jan 2026 2:05 PM ISTDrug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological upheaval since the internet,...
CDSCO Panel Backs Label Change Allowing Endocrinologists, Rheumatologists to Prescribe Amgen's Romosozumab Parthika Patel12 Jan 2026 9:12 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval for amending the...
Biocon Biologics secures market entry date for Denosumab biosimilars in Europe, Rest of World Ruchika Sharma2 Dec 2025 11:38 AM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps Dr. Kamal Kant Kohli24 Oct 2025 8:15 PM ISTThe FDA has approved Tezspire (tezepelumab-ekko), a biologic therapy by Amgen and AstraZeneca, as an add-on maintenance treatment for patients aged 12...
AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps Ruchika Sharma23 Oct 2025 11:45 AM ISTAstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on therapy with intranasal corticosteroids...
AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps Ruchika Sharma18 Oct 2025 11:30 AM ISTAstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged...
Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US Ruchika Sharma1 Oct 2025 12:05 PM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
Amgen announces USD 650 million expansion of US manufacturing network Ruchika Sharma30 Sept 2025 10:00 AM ISTThousand Oaks: Amgen has announced a USD 650 million expansion of its U.S. manufacturing network, creating hundreds of new...
AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps Ruchika Sharma22 Sept 2025 2:00 PM ISTCambridge: AstraZeneca and Amgen's Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult...
Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million Ruchika Sharma2 Sept 2025 11:45 AM ISTNew York: Royalty Pharma plc has announced that the company has acquired a royalty interest in Amgen's Imdelltra, a first-in-class DLL3 targeting...
Royalty Pharma to Buy USD 950 Million Royalty Stake in Amgen's Small Cell Lung Cancer Drug Imdelltra Parthika Patel26 Aug 2025 12:45 PM ISTThe deal gives Royalty Pharma access to roughly 7% of global net sales of the therapy, Imdelltra, which won U.S. approval last year.
